VPHM, Wyeth HCV setback

ViroPharma (VPHM) and partner Wyeth-Ayerst, a subsidiary of American Home Products (AHP), halted development of VP 50406 to treat hepatitis C virus (HCV) infection following Phase IIa data. VPHM said ...